TrialClinical pharmacokinetics2019

Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials.

Yulan Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.